Answers are grounded in this paper and cite their sources.
Background: Carbapenem-resistant gram-negative rod bacteremia (CRGNR-B) is emerging as a formidable challenge, complicating patient management and outcomes in liver transplantation (LT).This study aimed to investigate the incidence, mortality, and risk factors associated with CRGNR-B within 90 days following LT.Methods: A retrospective nested case-control study was conducted using single centric LT data (n=1,379).CRGNR-B cases were matched 1:5 with control patients for analyzing survival and risk factors for CRGNR-B. Results:The incidence of CRGNR-B within 90 days post-LT was 6.5% (n=87).The CRGNR-B group showed significantly lower 1-year post-LT survival compared to the control group (37.9% vs. 90.0%,p<0.001).CRGNR-B was significantly correlated with increased mortality after adjustment of covariates (adjusted hazard ratio, 5.66; 95% confidence interval [CI], 3.89-8.24;p<0.001).Key risk factors identified include higher pretransplant model for end-stage liver disease scores (odds ratio [OR], 1.05; 95% CI, 1.01-1.09;p=0.006), encephalopathy prior to transplant (OR, 2.79; 95% CI, 1.48-5.30;p=0.002), retransplantation (OR, 10.4; 95% CI, 2.79-42.1;p<0.001), each 60-minute increase in cold ischemic time (OR, 1.20; 95% CI, 1.01-1.42;p=0.037), and bile duct complications (OR, 6.16; 95% CI, 2.66-14.2;p<0.001). Conclusion:The occurrence of CRGNR-B within 90 days post-LT poses a significant risk to patient survival, with identifiable pre-and peri-transplant risk factors.These findings underscore the importance of targeted preventive measures, early detection, and effective management strategies to enhance outcomes for LT recipients.
No takes yet. Share an insight, caveat, or question.
Min et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: